7Baggers

IRadimed Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Operating Profit  
 Net Income  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 03.346.6710.0113.3516.6920.0223.36Milllion

IRadimed Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 
                                               
  revenue20,409,400 19,510,637 19,389,167 18,325,959 17,928,876 17,598,119 17,452,176 16,504,640 16,130,396 15,475,083 23,361,424 13,407,272 12,721,569 12,310,710 18,643,252 10,907,302 9,810,423 9,223,996 8,546,043 7,699,096 6,794,692 8,677,541 10,890,653 9,963,299 9,225,596 8,437,593 8,339,392 7,614,655 7,376,785 7,108,151 6,704,944 5,689,724 5,524,364 5,162,560 5,990,273 7,673,217 9,868,905 8,964,153 8,799,256 8,193,616 7,609,143 6,991,705 3,583,504 3,811,947 4,700,369 
  yoy13.84% 10.87% 11.10% 11.04% 11.15% 13.72% -25.29% 23.10% 26.80% 25.70% 25.31% 22.92% 29.67% 33.46% 118.15% 41.67% 44.38% 6.30% -21.53% -22.73% -26.35% 2.84% 30.59% 30.84% 25.06% 18.70% 24.38% 33.83% 33.53% 37.69% 11.93% -25.85% -44.02% -42.41% -31.92% -6.35% 29.70% 28.21% 145.55% 114.95% 61.88%     
  qoq4.61% 0.63% 5.80% 2.21% 1.88% 0.84% 5.74% 2.32% 4.23% -33.76% 74.24% 5.39% 3.34% -33.97% 70.92% 11.18% 6.36% 7.93% 11.00% 13.31% -21.70% -20.32% 9.31% 8.00% 9.34% 1.18% 9.52% 3.22% 3.78% 6.01% 17.84% 2.99% 7.01% -13.82% -21.93% -22.25% 10.09% 1.87% 7.39% 7.68% 8.83% 95.11% -5.99% -18.90%  
  cost of revenue4,454,408 4,667,831 4,628,308 4,134,253 3,919,283 4,210,396 4,039,236 3,667,256 3,943,904 3,753,635 4,879,195 2,864,534 2,581,806 2,931,186 3,728,303 2,501,745 2,478,122 2,161,680 2,106,609 1,958,036 1,864,587 2,213,730 2,741,838 2,168,208 1,858,288 2,047,827 1,982,492 1,826,716 1,710,890 1,691,535 1,640,197 1,307,767 1,234,314 1,387,618 1,304,088 1,405,884 1,739,067 1,705,797 1,499,978 1,590,222 1,422,027 1,328,180 918,696 959,593 869,745 
  gross profit15,954,992 14,842,806 14,760,859 14,191,706 14,009,593 13,387,723 13,412,940 12,837,384 12,186,492 11,721,448 18,482,229 10,542,738 10,139,763 9,379,524 14,914,949 8,405,557 7,332,301 7,062,316 6,439,434 5,741,060 4,930,105 6,463,811 8,148,815 7,795,091 7,367,308 6,389,766 6,356,900 5,787,939 5,665,895 5,416,616 5,064,747 4,381,957 4,290,050 3,774,942 4,686,185 6,267,333 8,129,838 7,258,356 7,299,278 6,603,394 6,187,116 5,663,525 2,664,808 2,852,354 3,830,624 
  yoy13.89% 10.87% 10.05% 10.55% 14.96% 14.22% -27.43% 21.77% 20.19% 24.97% 23.92% 25.43% 38.29% 32.81% 131.62% 46.41% 48.73% 9.26% -20.98% -26.35% -33.08% 1.16% 28.19% 34.68% 30.03% 17.97% 25.51% 32.09% 32.07% 43.49% 8.08% -30.08% -47.23% -47.99% -35.80% -5.09% 31.40% 28.16% 173.91% 131.51% 61.52%     
  qoq7.49% 0.56% 4.01% 1.30% 4.65% -0.19% 4.48% 5.34% 3.97% -36.58% 75.31% 3.97% 8.11% -37.11% 77.44% 14.64% 3.82% 9.67% 12.16% 16.45% -23.73% -20.68% 4.54% 5.81% 15.30% 0.52% 9.83% 2.15% 4.60% 6.95% 15.58% 2.14% 13.65% -19.45% -25.23% -22.91% 12.01% -0.56% 10.54% 6.73% 9.24% 112.53% -6.58% -25.54%  
  gross margin %78.17% 76.08% 76.13% 77.44% 78.14% 76.07% 76.86% 77.78% 75.55% 75.74% 79.11% 78.63% 79.71% 76.19% 80.00% 77.06% 74.74% 76.56% 75.35% 74.57% 72.56% 74.49% 74.82% 78.24% 79.86% 75.73% 76.23% 76.01% 76.81% 76.20% 75.54% 77.02% 77.66% 73.12% 78.23% 81.68% 82.38% 80.97% 82.95% 80.59% 81.31% 81.00% 74.36% 74.83% 81.50% 
  operating expenses:                                             
  general and administrative4,279,993 4,610,832 3,873,152 3,967,799 4,104,961 3,991,211 4,273,454 3,615,020 3,313,080 3,920,510 3,449,805 2,881,590 2,402,795 2,715,950 -290,627 2,252,274 2,564,619 2,430,369 2,206,990 2,196,935 5,002,427 2,862,727 2,968,476 2,609,722 2,460,372 2,412,696 2,147,155 2,181,839 2,078,356 2,303,532 2,152,692 2,551,290 2,189,925 2,107,257 1,577,849 1,869,927 3,088,205 2,259,722 2,140,810 1,675,784 1,985,269 1,968,017 1,331,922 1,261,872 1,130,484 
  sales and marketing4,009,640 4,176,273 4,517,497 3,795,320 3,476,460 3,827,165 3,329,218 2,864,469 2,948,425 2,999,976 5,245,007 3,037,209 2,907,788 3,069,556 3,465,546 2,585,702 2,469,777 2,379,124 3,068,700 2,282,491 2,374,134 2,433,567 2,562,113 2,297,002 2,199,823 2,110,652 2,049,188 1,784,418 1,516,044 1,645,936 1,562,743 1,251,901 1,323,539 1,364,776 1,238,898 1,346,742 1,409,758 1,283,048 1,306,396 1,206,203 1,104,682 1,088,696 792,101 880,711 864,519 
  research and development877,362 624,245 569,993 639,467 801,129 821,000 650,435 452,555 961,952 793,716 867,889 491,643 662,599 519,095 515,231 480,696 453,679 475,817 512,718 476,876 482,654 430,282 379,310 369,526 331,310 352,573 367,715 373,583 395,988 379,826 349,559 382,704 449,011 541,290 364,216 457,134 291,822 234,336 499,996 518,562 403,447 342,301 315,407 303,463 225,500 
  total operating expenses9,166,995 9,411,350 8,960,642 8,402,586 8,382,550 8,639,376 8,253,107 6,932,044 7,223,457 7,714,202 9,562,701 6,410,442 5,973,182 6,304,601 3,690,150 5,318,672 5,488,075 5,285,310 5,788,408 4,956,302 7,859,215 5,726,576 5,909,899 5,276,250 4,991,505 4,875,921 4,564,058 4,339,840 3,990,388 4,329,294 4,064,994 4,185,895 3,962,475 4,013,323 3,180,963 3,673,803 4,789,785 3,777,106 3,947,202 3,400,549 3,493,398 3,399,014 2,439,430 2,446,046 2,220,503 
  income from operations6,787,997 5,431,456 5,800,217 5,789,120 5,627,043 4,748,347 5,159,833 5,905,340 4,963,035 4,007,246 8,919,528 4,132,296 4,166,581 3,074,923 11,224,799 3,086,885 1,844,226 1,777,006 651,026 784,758 -2,929,110 737,235 2,238,916 2,518,841 2,375,803 1,513,845 1,792,842 1,448,099 1,675,507 1,087,322 999,753 196,062 327,575  1,505,222 2,593,530 3,340,053 3,481,250 3,352,076 3,202,845 2,693,718 2,264,511 225,378 406,308 1,610,121 
  yoy20.63% 14.39% 12.41% -1.97% 13.38% 18.49% -42.15% 42.91% 19.12% 30.32% -20.54% 33.87% 125.93% 73.04% 1624.17% 293.36% -162.96% 141.04% -70.92% -68.84% -223.29% -51.30% 24.88% 73.94% 41.80% 39.23% 79.33% 638.59% 411.49%  -33.58% -92.44% -90.19%  -55.10% -19.02% 23.99% 53.73% 1387.31% 688.28% 67.30%     
  qoq24.98% -6.36% 0.19% 2.88% 18.51% -7.97% -12.62% 18.99% 23.85% -55.07% 115.85% -0.82% 35.50% -72.61% 263.63% 67.38% 3.78% 172.95% -17.04% -126.79% -497.31% -67.07% -11.11% 6.02% 56.94% -15.56% 23.81% -13.57% 54.09% 8.76% 409.92% -40.15%   -41.96% -22.35% -4.06% 3.85% 4.66% 18.90% 18.95% 904.76% -44.53% -74.77%  
  operating margin %33.26% 27.84% 29.91% 31.59% 31.39% 26.98% 29.57% 35.78% 30.77% 25.89% 38.18% 30.82% 32.75% 24.98% 60.21% 28.30% 18.80% 19.27% 7.62% 10.19% -43.11% 8.50% 20.56% 25.28% 25.75% 17.94% 21.50% 19.02% 22.71% 15.30% 14.91% 3.45% 5.93%  25.13% 33.80% 33.84% 38.84% 38.09% 39.09% 35.40% 32.39% 6.29% 10.66% 34.26% 
  other income539,247 513,973 544,160 629,201 642,217 495,154 521,810 503,192 335,387 342,409   13,102 14,915 -107,101 7,143 13,195 -5,663 13,507 9,352 17,852 98,502 115,249 110,064 78,025 92,574 83,072 42,555 27,838 40,072 32,000 28,715 21,138 29,524 9,588   31,778 -36,275 64,709 46,135 46,815 1,568.75  11,631 
  income before benefit from income taxes7,327,244 5,945,429 6,344,377 6,418,321 6,269,260 5,243,501 5,681,643 6,408,532 5,298,422 4,349,655 1,680,698 4,237,479 4,179,683 3,060,008 11,117,698 3,094,028 1,857,421 1,771,343 664,533 794,110 -2,911,258 835,737 2,354,165 2,628,905 2,453,828 1,606,419 1,875,914 1,490,654 1,703,345 1,127,394 1,031,753 224,777 348,713  1,514,810 2,589,513 3,335,384 3,513,028 3,315,801 3,267,554 2,739,853 2,311,326 170,554 397,500 1,621,752 
  benefit from income tax expense1,553,283 1,258,000 1,197,599 1,368,830 1,368,036 1,106,968 1,141,957 1,341,352 1,118,582 943,589 2,062,274 810,375 938,631 573,295         74,969 174,035 364,987    348,377 286,198 12,126.75 32,384  24,483            
  net income5,773,961 4,687,429 5,146,778 5,049,491 4,901,224 4,136,533 4,539,686 5,067,180 4,179,840 3,406,066 7,395,683 3,427,104 3,241,052 2,486,713 8,593,884 2,576,261 1,469,694 1,386,849 637,414 1,074,646 -2,112,270 1,769,211 3,241,683 2,454,870 2,088,841 1,845,565 1,707,013 2,400,273 1,354,968 841,196 183,638 192,393 357,073 -233,340 1,140,800 1,560,484 2,231,251 2,282,011 2,404,706 1,867,148 1,770,571 1,487,495 270,821 237,357 1,018,821 
  yoy17.81% 13.32% 13.37% -0.35% 17.26% 21.45% -38.62% 47.86% 28.97% 36.97% -13.94% 33.03% 120.53% 79.31% 1248.24% 139.73% -169.58% -21.61% -80.34% -56.22% -201.12% -4.14% 89.90% 2.27% 54.16% 119.40% 829.55% 1147.59% 279.47% -460.50% -83.90% -87.67% -84.00% -110.23% -52.56% -16.42% 26.02% 53.41% 787.93% 686.64% 73.79%     
  qoq23.18% -8.92% 1.93% 3.03% 18.49% -8.88% -10.41% 21.23% 22.72% -53.95% 115.80% 5.74% 30.33% -71.06% 233.58% 75.29% 5.97% 117.57% -40.69% -150.88% -219.39% -45.42% 32.05% 17.52% 13.18% 8.12% -28.88% 77.15% 61.08% 358.07% -4.55% -46.12% -253.03% -120.45% -26.89% -30.06% -2.22% -5.10% 28.79% 5.45% 19.03% 449.25% 14.10% -76.70%  
  net income margin %28.29% 24.02% 26.54% 27.55% 27.34% 23.51% 26.01% 30.70% 25.91% 22.01% 31.66% 25.56% 25.48% 20.20% 46.10% 23.62% 14.98% 15.04% 7.46% 13.96% -31.09% 20.39% 29.77% 24.64% 22.64% 21.87% 20.47% 31.52% 18.37% 11.83% 2.74% 3.38% 6.46% -4.52% 19.04% 20.34% 22.61% 25.46% 27.33% 22.79% 23.27% 21.28% 7.56% 6.23% 21.68% 
  net income per share                                             
  basic0.45 0.37 0.41 0.4 0.39 0.33 0.36 0.4 0.33 0.27 0.58 0.27 0.26 0.2 0.7 0.21 0.12 0.11 0.05 0.09 -0.17 0.15 0.28 0.22 0.19 0.17 0.16 0.22 0.13 0.08 0.02 0.02 0.03 -0.02 0.11 0.15 0.21 0.21 0.21 0.17 0.16 0.14 0.01 0.02 0.15 
  diluted0.45 0.37 0.4 0.4 0.38 0.32 0.36 0.4 0.33 0.27 0.59 0.27 0.26 0.2 0.68 0.2 0.12 0.11 0.05 0.09 -0.17 0.14 0.26 0.2 0.17 0.15 0.14 0.2 0.11 0.07 0.01 0.02 0.03 -0.02 0.1 0.13 0.19 0.19 0.18 0.15 0.15 0.12 0.02 0.02 0.11 
  weighted-average shares outstanding:                                             
  basic12,715,872 12,714,224 12,670,216 12,669,741 12,664,920 12,662,526 12,602,948 12,602,581 12,596,032 12,593,033 12,562,856 12,564,636 12,560,812 12,552,817 12,346,173 12,331,062 12,313,563 12,310,577 12,123,556 12,243,362 12,076,399 11,891,428 11,282,214 11,369,404 11,163,506 11,029,639 10,758,752 10,824,421 10,651,619 10,608,387 10,638,858 10,565,598 10,687,746 10,740,979 10,818,427 10,684,650 10,778,673 11,095,950 11,003,272 11,028,551 10,974,448 10,906,224 8,743,461 10,112,139 7,000,000 
  diluted12,835,408 12,825,672 12,783,558 12,778,446 12,757,996 12,749,973 12,722,530 12,735,837 12,723,017 12,686,699 12,635,971 12,631,129 12,632,755 12,655,518 12,590,853 12,603,566 12,554,828 12,521,279 12,440,086 12,493,309 12,076,399 12,365,605 12,276,444 12,309,948 12,226,660 12,227,696 12,110,117 12,195,870 12,011,475 11,879,889 11,720,316 11,643,044 11,727,473 10,740,979 11,989,681 11,867,997 11,966,289 12,326,108 12,556,887 12,382,531 12,107,707 11,977,959 10,219,143 11,269,358 8,878,170 
  other income           3,668.75 105,183                                  
  benefit from income tax benefit              2,523,814 517,767 387,727 384,494    -933,474                        
  benefit from income tax (benefit) expense                  -503,249.5 -280,536 -798,988                         
  benefit from income taxes                                  374,010 1,029,029 1,104,133 1,231,017 911,095 1,400,406 969,282 823,831 -100,267 160,143 602,931 
  other comprehensive income:                                             
  change in fair value of available-for-sale securities, net of tax (benefit) expense of (6,369) and 70 for the three months ended september 30, 2015 and 2014, respectively, and (8,833) and (2,681) for the nine months ended september 30, 2015 and 2014, respectively                                             
  realized gain on available-for-sale securities reclassified to net income, net of tax of 70 and 2,560 for the three and nine months ended september 30, 2014, respectively                                             
  comprehensive income                                      1,277,717.75 1,856,807 1,757,173 1,496,891 249,348 237,357 1,020,347 
  change in fair value of available-for-sale securities, net of tax (benefit) expense of (8,249) and 821 for the three months ended june 30, 2015 and 2014, respectively, and (2,464) and 1,993 for the six months ended june 30, 2015 and 2014, respectively                                             
  change in fair value of available-for-sale securities, net of tax expense of 5,785 and 1,171 for the three months ended march 31, 2015 and 2014, respectively                                         9,396    
  change in fair value of available-for-sale securities, net of tax benefit of 70 and (432) for the three months ended september 30, 2014 and 2013, respectively, and 2,063 and (2,681) for the nine months ended september 30, 2014 and 2013, respectively                                          958 130  
  change in fair value of available-for-sale securities, net of tax benefit of 821 and (2,326) for the three months ended june 30, 2014 and 2013, respectively, and 1,993 and (2,249) for the six months ended june 30, 2014 and 2013, respectively                                            1,526 

We provide you with 20 years income statements for IRadimed stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IRadimed stock. Explore the full financial landscape of IRadimed stock with our expertly curated income statements.

The information provided in this report about IRadimed stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.